07/11/2025
Techno Biomed Pvt. Ltd. is proud to be part of the novel initiative by the Kathmandu Institute of Child Health (KIOCH) aimed at enhancing child healthcare in Nepal under the visionary leadership of Prof. Dr. Bhagwan Koirala and his dedicated team.
The session also highlighted the cutting-edge technologies used in Newborn Screening (NBS) — including TR-FIA Analyzer and UPLC-MS/MS Technology — which enable accurate, high-throughput, and reliable testing outcomes.
As part of this initiative, Techno Biomed Pvt. Ltd. proudly hosted a Continuing Medical Education (CME) session at KIOCH in collaboration with Fenghua Newborn Screening. We were honored to have Ms. Emily Jing, Product Manager at Fenghua, join us virtually to share her expert insights on the clinical importance of early neonatal screening and best-practice laboratory workflows.
Key screening markers covered:
• Phenylketonuria (PKU): Screening for amino acid metabolism disorder
• G6PD deficiency: Detection of enzyme deficiency associated with hemolytic anemia
• TSH/T4: Early detection of congenital hypothyroidism
• 17-Alpha Hydroxyprogesterone (17-OHP): Screening for congenital adrenal hyperplasia
• Total Galactose (TGAL): Screening for galactosemia
• GALT (Galactose-1-phosphate uridyl transferase): Confirmation of defective galactose metabolism
• Biotinidase: Screening for biotin metabolism deficiency
• Immunoreactive trypsinogen (IRT): Screening marker for cystic fibrosis
We extend our sincere gratitude to KIOCH and all participating pediatric and neonatal clinicians for their valuable engagement. Techno Biomed remains committed to strengthening newborn screening capacity in Nepal through ongoing training, advanced technology, and meaningful collaborations.
At Techno Biomed, we take pride in offering a wide range of advanced diagnostic solutions, supporting healthcare in Nepal with innovation, accuracy, and trust.
